95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.79%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.44%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-17.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-17.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.88%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-21.88%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.02%
Share reduction more than 1.5x AEM's 0.23%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.01%
Reduced diluted shares while AEM is at 0.18%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-50.24%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-15.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-32.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
5.30%
10Y revenue/share CAGR under 50% of AEM's 29.19%. Michael Burry would suspect a lasting competitive disadvantage.
17.64%
5Y revenue/share CAGR under 50% of AEM's 49.34%. Michael Burry would suspect a significant competitive gap or product weakness.
-28.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
13.22%
10Y OCF/share CAGR under 50% of AEM's 116.69%. Michael Burry would worry about a persistent underperformance in cash creation.
54.57%
5Y OCF/share CAGR at 75-90% of AEM's 72.12%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-25.62%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
18.59%
Net income/share CAGR at 50-75% of AEM's 31.94%. Martin Whitman might question if the firm’s product or cost base lags behind.
235.00%
5Y net income/share CAGR at 50-75% of AEM's 393.95%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-23.01%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
61.85%
10Y equity/share CAGR at 50-75% of AEM's 101.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
29.21%
Below 50% of AEM's 89.96%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
22.22%
Below 50% of AEM's 77.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
46.20%
10Y dividend/share CAGR at 50-75% of AEM's 71.08%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
91.79%
Below 50% of AEM's 257.34%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
76.29%
3Y dividend/share CAGR at 75-90% of AEM's 95.85%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
57.36%
AR growth well above AEM's 9.22%. Michael Burry fears inflated revenue or higher default risk in the near future.
-50.99%
Inventory is declining while AEM stands at 12.02%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.02%
Positive asset growth while AEM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.06%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.84%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.